Elliott Marshall Antman

13PUBLICATIONS
47CO-AUTHORS
HaematologyTime-series analysisHaematological tumoursCardiology (incl. cardiovascular diseases)Biofabrication
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 10, 2025
Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial.

Robert S Semco, Regan W Bergmark, Sabina A Murphy

|Jun 03, 2024
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation.

Brian A Bergmark, Jeong-Gun Park, Rose A Hamershock

|Jan 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation.

Siddharth M Patel, Eugene Braunwald, Jan Steffel

|Oct 19, 2022
Atrial Fibrillation - What Is It and How Is It Treated?

Elliott M Antman, Jane A Leopold, William H Sauer

|Oct 05, 2022
Atrial Fibrillation and Catheter Ablation.

Elliott M Antman, Jane A Leopold, William H Sauer

|Dec 28, 2021
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.

Marc P Bonaca, Elliott M Antman, Jonathan W Cunningham

Pageof 3

Frequent Collaborators

5 joint publications

Robert P Giugliano

4 joint publications

Christian T Ruff

4 joint publications

Eugene Braunwald

2 joint publications

Brian A Bergmark